Literature DB >> 12540806

Genetic alterations in hepatocellular adenomas.

Paulette Bioulac-Sage, Pierre Laurent-Puig, Charles Balabaud, Jessica Zucman-Rossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12540806     DOI： 10.1053/jhep.2003.50058

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  6 in total

1.  Unique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control.

Authors:  Christopher A Reed; Christopher N Mayhew; A Kathleen McClendon; Erik S Knudsen
Journal:  J Biol Chem       Date:  2009-11-02       Impact factor: 5.157

Review 2.  The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy.

Authors:  Erik S Knudsen; Purva Gopal; Amit G Singal
Journal:  Am J Pathol       Date:  2013-12-31       Impact factor: 4.307

3.  RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1.

Authors:  C A Reed; C N Mayhew; A K McClendon; X Yang; A Witkiewicz; E S Knudsen
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

4.  Expression of liver fatty acid binding protein in hepatocellular carcinoma.

Authors:  Soo-Jin Cho; Linda D Ferrell; Ryan M Gill
Journal:  Hum Pathol       Date:  2015-12-18       Impact factor: 3.466

5.  RB tumor suppressive function in response to xenobiotic hepatocarcinogens.

Authors:  Christopher Reed; Jack Hutcheson; Christopher N Mayhew; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Am J Pathol       Date:  2014-04-13       Impact factor: 4.307

6.  De novo 13q13.3-21.31 deletion involving RB1 gene in a patient with hemangioendothelioma of the liver.

Authors:  Novella Rapini; Roberta Lidano; Silvia Pietrosanti; Giuseppina Vitiello; Chiara Grimaldi; Diana Postorivo; Anna Maria Nardone; Francesca Del Bufalo; Francesco Brancati; Maria Luisa Manca Bitti
Journal:  Ital J Pediatr       Date:  2014-01-16       Impact factor: 2.638
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.